A recent study from the United States has uncovered a worrying trend: cervical cancer rates are rising in rural areas, especially among certain groups of women.
While the research focuses on the US, its findings may hold important lessons for Malaysia, where rural communities also face health care challenges. Although the exact situation may differ, the study highlights how access to preventive care and treatment can dramatically affect outcomes in cervical cancer—a disease largely preventable with proper screening and vaccination.
The research, published in JAMA Network Open, analysed data collected over nearly two decades, involving more than 220,000 cases of cervical cancer. The researchers found that while urban areas saw either a decline or stabilisation in cervical cancer cases, rural areas experienced a steady increase since around 2012.
By 2019, women living in rural counties in the US had a 25% higher rate of new cervical cancer diagnoses than those in urban settings. Mortality rates were also significantly higher, with rural women facing a 42% greater risk of dying from the disease.
Why is this happening? Several factors are believed to contribute. Rural areas often have fewer healthcare providers, making it difficult for women to access regular cervical cancer screenings such as Pap smears or HPV tests.
Vaccination rates for human papillomavirus (HPV)—a key cause of cervical cancer—are also lower in these communities. Additionally, logistical difficulties such as transportation, financial constraints, and lack of health education can delay diagnosis and treatment.
The study also pointed out differences among ethnic groups within rural populations: White women in rural areas showed a consistent increase in cancer incidence, while data suggested rising rates among Black women as well, although numbers were too small for definitive conclusions. Hispanic women in rural areas actually saw declining incidence rates.
While Malaysia’s healthcare landscape is different from that of the US, with its own unique social and geographical factors, there are parallels worth noting. Many rural communities in Malaysia face barriers to accessing quality healthcare, including specialist services. Travel distances to health facilities, limited health awareness, and socioeconomic factors can all hinder timely screening and vaccination against HPV.
It is important to note that the US study used county-level data, which might mask differences within smaller communities. Also, smaller sample sizes made it difficult to analyse some trends in detail. Nevertheless, the large scale and rigorous methods offer valuable insights into how rural residency can affect cervical cancer outcomes.
For Malaysians, this research serves as a reminder of the importance of expanding preventive health measures nationwide. Increasing HPV vaccination coverage and making cervical cancer screening more accessible outside urban centres could significantly reduce future cases and deaths. Mobile health services, outreach programmes, and education targeting rural populations would be crucial steps forward.
Cervical cancer is a largely preventable disease when women have access to early detection and vaccination. The contrast between rural and urban experiences in the US shows how geography can create health inequalities that have life-or-death consequences. While Malaysian data may not mirror these findings exactly, the message is clear: improving access to preventive care for all women is essential in reducing the burden of cervical cancer.
As Malaysia continues to develop its healthcare system, paying close attention to rural health disparities will be vital. The US study highlights potential risks if preventive care remains unevenly distributed. By learning from international research and adapting strategies to local needs, Malaysia can work towards ensuring that every woman—regardless of where she lives—has an equal chance at a healthy life free from preventable cancers like cervical cancer.
